RVTY
Undervalued by 27.8% based on the discounted cash flow analysis.
Market cap | $15.29 Billion |
---|---|
Enterprise Value | $17.32 Billion |
Dividend Yield | $0.28 (0.225879315908358%) |
Earnings per Share | $1.44 |
Beta | 1.05 |
Outstanding Shares | 123,354,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 79.15 |
---|---|
PEG | 126.91 |
Price to Sales | 4.4 |
Price to Book Ratio | 1.59 |
Enterprise Value to Revenue | 6.35 |
Enterprise Value to EBIT | 38.66 |
Enterprise Value to Net Income | 53 |
Total Debt to Enterprise | 0.18 |
Debt to Equity | 0.41 |
No data
No data
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...